|
Midazolam Clinical Trials
9 actively recruiting trials across 4 locations
Also known as: Dormicum, Hypnovel, Randomized Controlled Phase Intervention 2, Seizalam
Other5 trials
Phase 3
Gilbert, Arizona1 trial
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Banner MD Anderson Cancer Center
Phase 1/2
Fayetteville, Arkansas1 trial
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Highlands Oncology Group
Phase 1
Atlanta, Georgia1 trial
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
Peachford Hospital-Atlanta Behavioral Research
Phase 3
Baltimore, Maryland1 trial
Ketamine for Multiple Sclerosis Fatigue
Johns Hopkins University
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.